Replies to post #65941 on Biotech Values

[DewDiligence]

VRUS – Roadmap of R7128 results in phase-1
combination study with peg-ifn and ribavirin.

 
        Dose     HCV    Trtmnt     iHub 
 Cohort (BID)  Genotype  Line    Reference 
   1    500mg     1      1st    #msg-28837612 
   2   1500mg     1      1st    #msg-28837612 
   3   1000mg     1      1st    #msg-31218459 
   4   1500mg    2/3     2nd    #msg-31999860